Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-011917

CEO and CFO bought 5,000 shares at $12.42 ($62,100)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2023-04-11 Purchase +5,000 $12.42 $62,100 5,271,177 D
Open-market purchases · 5,000 sh · avg $12.42 · $62,100
Loading xslF345X04/ownership.xml…